FY14.1 Phase I Awards

The Chemical and Biological Defense (CBD) SBIR Program received 66 Phase I proposals in response to the 14.1 DoD SBIR Solicitation, which closed on 22 January 2014. The 14.1 Solicitation contained five CBD SBIR topics. The Phase I proposals received a comprehensive technical evaluation in accordance with the evaluation criteria published in the Solicitation, and were prioritized for award. The CBD SBIR award process resulted in the identification of 12 Phase I proposals for negotiation and award. Awards will be made based on successful negotiations with the small business in addition to availability of funds.

Topic Title Company
CBD14-105 Burkholderia antibody molecules for therapeutics and diagnostics BIOO Scientific
CBD14-105 High-affinity monoclonal antibodies that target Burkholderia Polysaccharide DxDiscovery, Inc.
CBD14-104 GTS SST-OPS: DNA Origami-based Bioscavengers for Nerve Agent Sequestration General Technology Solutions LLC
CBD14-104 Porphyrin-DNA Origami Constructs as Bio-scavengers for Organophosphates Parabon NanoLabs, Inc.
CBD14-103 Synergist and smart micro-controls for enhanced SCBA equipment Mainstream Engineering Corporation
CBD14-103 A uMECS miniature blower for respiratory protection system Vibrant Composites, Inc.
CBD14-102 Phase-cancelled, broadband, graphene-based impedance sensor
CBD14-102 Sensitive and selective chemical sensor using molecularly-imprinted single layer graphene Polestar Technologies, Inc.
CBD14-102 Graphene based chemical agent detector Physical Optics Corporation
CBD14-101 Detection of "active" biological toxins by exploiting native binding specificities Binergy Scientific, Inc.
CBD14-101 Innovative concept for detection and identification of biological toxinx Phoebus Optoelectronics, LLC
CBD14-101 Development of Zeteo Toxic Agent Detection System (zTADS) Zeteo Tech LLC
Last Update: October 10, 2014